Streptomyces flavoviridis

Streptomyces flavoviridis is a bacterium species from the genus of Streptomyces which has been isolated from soil.[1][3][4] Streptomyces flavoviridis produces phleomycin and zorbamycin.[5][6]

Streptomyces flavoviridis
Scientific classification
Kingdom:
Bacteria
Phylum:
Actinobacteria
Class:
Actinobacteria
Order:
Actinomycetales
Family:
Streptomycetaceae
Genus:
Streptomyces
Species:
S. flavoviridis
Binomial name
Streptomyces flavoviridis
Preobrazhenskaya 1986[1]
Type strain
ATCC 19759, ATCC 19903, BCRC 11474, CBS 497.68, CCRC 11474, CGMCC 4.1960, DSM 40153, IFO 12772, IMET 42058, INA 2314, INA 2314/53 T, ISP 5153, JCM 4372 , KCC S-0372, NBRC 12772, NRRL ISP-5153, NRRL Y-6895, NRRL-ISP 5153, RIA 1039, UNIQEM 145, VKM Ac-754[2]
Synonyms

Actinomyces flavoviridis[3][4]

Further reading
  • Teresa Infanta S, Antony K.; Nisshanthini, S. D.; Palaniswamy, M.; Angayarkanni, J. (31 August 2013). "Purification of GidA protein, a novel topoisomerase II inhibitor produced by Streptomyces flavoviridis". World Journal of Microbiology and Biotechnology. 30 (2): 555–565. doi:10.1007/s11274-013-1475-1. PMID 23996636. S2CID 44423696.
  • Galm, U; Wendt-Pienkowski, E; Wang, L; George, NP; Oh, TJ; Yi, F; Tao, M; Coughlin, JM; Shen, B (January 2009). "The biosynthetic gene cluster of zorbamycin, a member of the bleomycin family of antitumor antibiotics, from Streptomyces flavoviridis ATCC 21892". Molecular BioSystems. 5 (1): 77–90. doi:10.1039/b814075h. PMC 3086045. PMID 19081934.
  • Rudolf, Jeffrey D.; Bigelow, Lance; Chang, Changsoo; Cuff, Marianne E.; Lohman, Jeremy R.; Chang, Chin-Yuan; Ma, Ming; Yang, Dong; Clancy, Shonda; Babnigg, Gyorgy; Joachimiak, Andrzej; Phillips, George N.; Shen, Ben (17 November 2015). "Crystal Structure of the Zorbamycin-Binding Protein ZbmA, the Primary Self-Resistance Element in ATCC21892". Biochemistry. 54 (45): 6842–6851. doi:10.1021/acs.biochem.5b01008. PMC 4809751. PMID 26512730.
  • Wang, L; Yun, BS; George, NP; Wendt-Pienkowski, E; Galm, U; Oh, TJ; Coughlin, JM; Zhang, G; Tao, M; Shen, B (March 2007). "Glycopeptide antitumor antibiotic zorbamycin from Streptomyces flavoviridis ATCC 21892: strain improvement and structure elucidation". Journal of Natural Products. 70 (3): 402–6. doi:10.1021/np060592k. PMC 2579990. PMID 17311457.
  • Setlow, edited by Jane K. (2003). Genetic engineering : principles and methods. New York: Kluwer Academic/Plenum. ISBN 0-306-47776-9.CS1 maint: extra text: authors list (link)
  • editor, Frank E. Koehn (2013). Natural products and cancer drug discovery. New York: Humana Press. ISBN 978-1-4614-4654-5.CS1 maint: extra text: authors list (link)

See also

References
  1. LPSN bacterio.net
  2. Straininfo of Streptomyces flavoviridis
  3. Deutsche Sammlung von Mikroorganismen und Zellkulturen
  4. UniProt
  5. ATCC
  6. Wang, L; Yun, BS; George, NP; Wendt-Pienkowski, E; Galm, U; Oh, TJ; Coughlin, JM; Zhang, G; Tao, M; Shen, B (March 2007). "Glycopeptide antitumor antibiotic zorbamycin from Streptomyces flavoviridis ATCC 21892: strain improvement and structure elucidation". Journal of Natural Products. 70 (3): 402–6. doi:10.1021/np060592k. PMC 2579990. PMID 17311457.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.